Cargando…

Hemospray for recurrent esophageal band ulcer bleeding

Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanglodkar, Uday A., Jothimani, Dinesh, Rela, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865909/
https://www.ncbi.nlm.nih.gov/pubmed/29594199
http://dx.doi.org/10.5114/ceh.2018.73668
_version_ 1783308769647656960
author Sanglodkar, Uday A.
Jothimani, Dinesh
Rela, Mohamed
author_facet Sanglodkar, Uday A.
Jothimani, Dinesh
Rela, Mohamed
author_sort Sanglodkar, Uday A.
collection PubMed
description Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a clear benefit. Hemospray (Cook Medical, Winston-Salem, North Carolina, USA) is a relatively new non-contact hemostatic modality used in the management of bleeding peptic ulcers. It is a nano-powder that can be sprayed over a larger mucosal area. Here we describe a patient with end stage liver disease who presented with recurrent bleeding from a deep esophageal ulcer following band ligation and sclerotherapy, effectively managed with multiple sessions of Hemospray.
format Online
Article
Text
id pubmed-5865909
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-58659092018-03-28 Hemospray for recurrent esophageal band ulcer bleeding Sanglodkar, Uday A. Jothimani, Dinesh Rela, Mohamed Clin Exp Hepatol Case Report Rebleeding after initially successful endoscopic variceal ligation (EVL) occurs in 20-60% of patients, most commonly from band ulcers, and is associated with 20-50% mortality. Although band ulcer bleeding has been treated in a number of different ways, no single therapeutic intervention has shown a clear benefit. Hemospray (Cook Medical, Winston-Salem, North Carolina, USA) is a relatively new non-contact hemostatic modality used in the management of bleeding peptic ulcers. It is a nano-powder that can be sprayed over a larger mucosal area. Here we describe a patient with end stage liver disease who presented with recurrent bleeding from a deep esophageal ulcer following band ligation and sclerotherapy, effectively managed with multiple sessions of Hemospray. Termedia Publishing House 2018-02-10 2018-03 /pmc/articles/PMC5865909/ /pubmed/29594199 http://dx.doi.org/10.5114/ceh.2018.73668 Text en Copyright: © 2018 Clinical and Experimental Hepatology http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Case Report
Sanglodkar, Uday A.
Jothimani, Dinesh
Rela, Mohamed
Hemospray for recurrent esophageal band ulcer bleeding
title Hemospray for recurrent esophageal band ulcer bleeding
title_full Hemospray for recurrent esophageal band ulcer bleeding
title_fullStr Hemospray for recurrent esophageal band ulcer bleeding
title_full_unstemmed Hemospray for recurrent esophageal band ulcer bleeding
title_short Hemospray for recurrent esophageal band ulcer bleeding
title_sort hemospray for recurrent esophageal band ulcer bleeding
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865909/
https://www.ncbi.nlm.nih.gov/pubmed/29594199
http://dx.doi.org/10.5114/ceh.2018.73668
work_keys_str_mv AT sanglodkarudaya hemosprayforrecurrentesophagealbandulcerbleeding
AT jothimanidinesh hemosprayforrecurrentesophagealbandulcerbleeding
AT relamohamed hemosprayforrecurrentesophagealbandulcerbleeding